Skip to main content
Chemfab Alkalis Ltd logo

Chemfab Alkalis Ltd — Investor Relations & Filings

Ticker · CHEMFAB ISIN · INE783X01023 LEI · 3358001VZX74GFCTZW69 BSE.NS Manufacturing
Filings indexed 392 across all filing types
Latest filing 2024-07-26 Regulatory Filings
Country IN India
Listing BSE.NS CHEMFAB

About Chemfab Alkalis Ltd

https://chemfabalkalis.com/

Chemfab Alkalis Ltd is a chemical manufacturing enterprise specializing in the chlor-alkali sector. The company primarily produces caustic soda (sodium hydroxide) in both lye and flake forms, alongside co-products such as liquid chlorine, hydrochloric acid, sodium hypochlorite, and compressed hydrogen gas. Notably, the organization was a pioneer in implementing energy-efficient membrane cell technology in its production processes. Its product portfolio serves diverse industrial applications, including water treatment, textile processing, paper and pulp manufacturing, aluminum refining, and the production of soaps and detergents. The company emphasizes operational efficiency and environmental compliance through advanced electrolysis techniques and rigorous quality control measures.

Recent filings

Filing Released Lang Actions
Board Meeting — CHEMFAB ALKALIS LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for th…
Regulatory Filings
2024-07-26 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for August 8, 2024. The agenda includes approval of unaudited quarterly financial results and allotment of shares under an employee stock option scheme. The letter references compliance with SEBI regulations and trading window closure. The document is short (1774 characters) and serves as an announcement of a future event rather than containing actual financial data or results. It does not contain the financial report itself but informs about the meeting where such reports will be considered. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a regulatory announcement that does not fit other specific categories like Interim Report or Earnings Release.
2024-07-26 English
Disclosure of material issue
Regulatory Filings Classification · 95% confidence The document is a short formal letter addressed to stock exchanges (BSE and NSE) regarding an operational update about commissioning new production lines and receiving consent to operate, which increases the company's capacity. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(4), which pertains to disclosure of material events. The content is an announcement of a business update rather than a financial report, audit, or detailed management discussion. The document length is only 1426 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-25 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2024-07-13 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialization of share certificates for the quarter ended 30th June 2024. It is a certificate from the Registrar and Share Transfer Agent to the company and then submitted to stock exchanges. The document is short (2771 characters) and is a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report publication but a regulatory filing confirming compliance with a specific regulation. Therefore, it fits best under Regulatory Filings (RNS).
2024-07-12 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter from Chemfab Alkalis Limited addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It mentions the upcoming announcement of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, but does not contain any financial data or the results themselves. The document is short (1943 characters) and serves as a notification about the trading window closure ahead of the financial results announcement. Therefore, it is neither a financial report nor a detailed regulatory filing but a regulatory announcement related to insider trading compliance. This fits best under Regulatory Filings (RNS).
2024-06-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.